Research-Use Tirzepatide 20mg CAS 2023788-19-2 – Factory Supply, Wholesale, Custom Synthesis Available

Tirzepatide 20mg (CAS 2023788-19-2) is a high - purity peptide powder (pharmacy grade, 99.9% purity) designed for research use only (not for personal use). As a dual GIP/GLP - 1 receptor agonist, tirzepatide 20mg has shown promising potential in pre - clinical and clinical research related to type 2 diabetes management and weight loss studies. Our factory specializes in producing, wholesaling, and customizing tirzepatide 20mg to meet diverse research needs, ensuring consistent quality and compliance with strict standards.

Key specifications of tirzepatide 20mg include a molecular formula of C₂₂₅H₃₄₈N₄₈O₆₈, a molecular weight of 4813, and an appearance as a white powder. The product is packaged as 10mg/vial (or customized) with 10 vials per box, supporting flexible order quantities (MOQ: 10 vials) for wholesale and research - scale needs. Our factory ensures each batch of tirzepatide 20mg meets 99.9% purity, suitable for advanced biochemical and pharmacological research.

Tirzepatide 20mg functions as a dual agonist for glucose - dependent insulinotropic polypeptide (GIP) and glucagon - like peptide - 1 (GLP - 1) receptors. This unique mechanism mimics natural gut hormones, enhancing insulin secretion, reducing glucagon release, and promoting satiety — key pathways studied in type 2 diabetes and obesity research. In pre - clinical models and clinical trials (e.g., SURMOUNT - 1), tirzepatide 20mg demonstrated superior glucose control and weight loss efficacy compared to single - receptor agonists like dulaglutide, making it a focal point for metabolic disorder research.

For research teams, our factory offers tailored solutions: wholesale pricing for bulk orders, custom synthesis for modified peptide variants, and strict quality control (including HPLC and MS testing) to ensure tirzepatide 20mg’s integrity. Whether exploring its role in diabetes pathophysiology, weight management mechanisms, or novel therapeutic applications, our tirzepatide 20mg provides a reliable tool for research use, with support for sample provision and technical consultation to align with your experimental goals.

As a leading factory in peptide synthesis, we leverage advanced solid - phase and liquid - phase synthesis techniques to produce tirzepatide 20mg with high purity and stability. Our production line is optimized for scale, enabling efficient wholesale supply while maintaining batch - to - batch consistency. Customization options include modified formulations, packaging sizes, and analytical method development, ensuring tirzepatide 20mg meets your specific research protocols (e.g., in vitro studies, animal model experiments).

Compliance with research standards is paramount: our tirzepatide 20mg is manufactured under GMP - like conditions (for research - grade materials) and accompanied by detailed COA (Certificate of Analysis) reporting purity, identity, and endotoxin levels. This documentation supports regulatory compliance for research institutions and pharmaceutical R & D teams investigating tirzepatide 20mg’s therapeutic potential or mechanistic pathways.